Substance / Medication

Ondansetron hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

116 trials linked to this intervention

116
Total Trials
19
Recruiting
46
With Results

Research Evidence

Published studies and systematic reviews

Sort:
[Treatment of vomiting in children patients with solid tumor by hewei zhiou recipe combined ondansetron hydrochloride].
Shi Xue, Liu Zheng-Mao, Zhu Xiu-Dan · Zhongguo Zhong Xi Yi Jie He Za Zhi · 2012
PMID: 22803424RCT
Development of HPTLC method for the estimation of ondansetron hydrochloride in bulk drug and sublingual tablets.
Mujtaba Ali, Kohli Kanchan, Ali J et al. · Drug Test Anal · 2013
PMID: 23413100Observational
Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
Krishnaiah Yellela S R, Rama Bukka, Raghumurthy Vanambattina et al. · Pharm Dev Technol · 2009
PMID: 18819031Observational
Ondansetron hydrochloride for the treatment of delirium after coronary artery surgery.
Bayindir O, Güden M, Akpinar B et al. · J Thorac Cardiovasc Surg · 2001
PMID: 11135174Observational
Acute myocardial ischemia after administration of ondansetron hydrochloride.
Bosek V, Hu P, Robinson L A · Anesthesiology · 2000
PMID: 10719974Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ondansetron hydrochloride (substance)
SNOMED CT
108419004
UMLS CUI
C0700478

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
116
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.